AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) Schedules Fourth Quarter And Fiscal Year 2025 Results Webcast
Lantern Pharma (NASDAQ: LTRN) will host a webcast to discuss its fourth quarter and fiscal year 2025 operating and financial results on March 30 at 4:30 p.m. Eastern Time. Management, led by President and Chief Executive Officer Panna Sharma, will review results for the period ended Dec. 31, 2025 and provide updates on upcoming milestones, clinical trials and developments related to its RADR (R) AI and machine learning platform. To view the full press release, visit https://ibn.fm/eRemF About Lantern Pharma Lantern Pharma (NASDAQ: LTRN) is an AI-driven biotechnology company focused on accelerating and optimizing the discovery, development, and commercialization of…